Nicotinell

Nicotine, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It is intended for adult smokers seeking to quit by providing a steady dose of nicotine to alleviate withdrawal symptoms and cravings. The product is manufactured under GMP conditions and packaged to preserve patch integrity during transport.

GNH USA supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards.

Nicotinell is a nicotine replacement therapy used to support smoking cessation by delivering nicotine through the skin, helping to manage cravings and withdrawal symptoms during the quitting process.

- Smoking cessation: provides a steady nicotine dose to reduce cravings and withdrawal symptoms, facilitating gradual reduction of tobacco use. - Tobacco dependence: offers controlled nicotine delivery that can be tapered over weeks, supporting patients who have difficulty quitting abruptly. - Relapse prevention: may be continued for a short period after quitting to maintain nicotine levels and lower the risk of returning to smoking.

Nicotinell may cause a range of skin‑related and systemic reactions, most of which are mild and transient.

Common Side Effects: - Skin irritation: redness, itching or mild rash at the application site, usually resolving after patch removal. - Sleep disturbance: vivid dreams or difficulty falling asleep, often improving when the patch is removed before bedtime. - Headache: mild to moderate headache that may occur during the initial days of therapy.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing indicating a possible hypersensitivity to nicotine or patch components. - Severe skin reaction: blistering, intense dermatitis, or ulceration at the site, requiring immediate discontinuation. - Cardiovascular events: chest pain, palpitations, or hypertension that may necessitate medical evaluation.

When using Nicotinell, certain precautions should be observed to minimize risks and ensure effective therapy. - Assess suitability: confirm patient is an adult smoker motivated to quit. - Avoid use with nicotine‑containing products: do not combine with cigarettes, e‑cigarettes or other NRTs. - Monitor cardiovascular status: caution in patients with heart disease or hypertension. - Observe skin condition: discontinue if severe irritation or allergic reaction occurs. - Store at room temperature: keep patches in original packaging, protect from moisture and direct sunlight.

Nicotinell can interact with other medicines, altering nicotine levels or cardiovascular effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Beta‑blockers: may mask tachycardia from nicotine. - CYP2A6 inhibitors: elevate nicotine plasma concentrations.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase nausea. - Antihypertensives: nicotine may reduce blood‑pressure‑lowering effect. - Theophylline: nicotine may increase metabolism, reducing efficacy.